These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21245674)

  • 1. Mammography utilization in women aged 40-49 years: the French EDIFICE survey.
    Pivot X; Eisinger F; Blay JY; Coscas Y; Calazel-Benque A; Viguier J; Roussel C; Morère JF
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S16-9. PubMed ID: 21245674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening in women aged 50-74 years: is there room for improvement?
    Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening in France: results of the EDIFICE survey.
    Pivot X; Rixe O; Morere J; Coscas Y; Cals L; Namer M; Serin D; Dolbeault S; Eisinger F; Roussel C; Blay J
    Int J Med Sci; 2008 May; 5(3):106-12. PubMed ID: 18566655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inequalities in uptake of breast cancer screening in Spain: analysis of a cross-sectional national survey.
    Martín-López R; Jiménez-García R; Lopez-de-Andres A; Hernández-Barrera V; Jiménez-Trujillo I; Gil-de-Miguel A; Carrasco-Garrido P
    Public Health; 2013 Sep; 127(9):822-7. PubMed ID: 23773337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey.
    Duport N; Ancelle-Park R
    Eur J Cancer Prev; 2006 Jun; 15(3):219-24. PubMed ID: 16679864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of breast cancer screening in women aged over 75 years: a controversy to come?
    Eisinger F; Viguier J; Blay JY; Morère JF; Coscas Y; Roussel C; Pivot X
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S13-5. PubMed ID: 21245673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
    Séradour B; Allemand H; Weill A; Ricordeau P
    Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Do unto others as you would have them do unto you": breast imagers' perspectives regarding screening mammography for others and for themselves--do they practice what they preach?
    Lee J; Gordon PB; Whitman GJ
    AJR Am J Roentgenol; 2015 Jun; 204(6):1336-44. PubMed ID: 26001246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the elimination of cost sharing for mammographic breast cancer screening among rural US women: A natural experiment.
    Peppercorn J; Horick N; Houck K; Rabin J; Villagra V; Lyman GH; Wheeler SB
    Cancer; 2017 Jul; 123(13):2506-2515. PubMed ID: 28195644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer screening in France: third edition of the EDIFICE survey.
    Viguier J; Morère JF; Touboul C; Coscas Y; Blay JY; Lhomel C; Pivot X; Eisinger F
    Eur J Cancer Prev; 2015 Jun; 24 Suppl():S68-72. PubMed ID: 26016790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast cancer screening in thirteen French departments].
    Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Dialla PO; Pornet C; Poillot ML; Soler-Michel P; Sarlin N; Lunaud P; Desmidt P; Paré E; Mathis C; Rymzhanova R; Kuntz-Huon J; Exbrayat C; Bataillard A; Régnier V; Kalecinski J; Quantin C; Dumas A; Gentil J; Amiel P; Chauvin F; Dancourt V; Arveux P
    Bull Cancer; 2015 Feb; 102(2):126-38. PubMed ID: 25636359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do reproductive and hormonal risk factors for breast cancer associate with attendance at mammography screening?
    Lagerlund M; Sontrop JM; Zackrisson S
    Cancer Causes Control; 2013 Sep; 24(9):1687-94. PubMed ID: 23737028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mammography as a breast cancer screening tool in six districts in France.
    Lacour A; Mamelle N; Lafont S; Bazin B; Dubuc M; Exbrayat C; Trugeon A; Grosclaude P
    Cancer Detect Prev; 1997; 21(5):460-70. PubMed ID: 9307849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in mammography utilization for breast cancer screening in a Middle-Eastern country: Lebanon 2005-2013.
    Haddad FG; Kourie HR; Adib SM
    Cancer Epidemiol; 2015 Dec; 39(6):819-24. PubMed ID: 26651440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer prevention behaviour: a perspective of women from three language regions of Switzerland].
    Glaus A; Fäh B; Hornung R; Senn H; Stiefel F
    Pflege; 2004 Dec; 17(6):385-94. PubMed ID: 15648588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.
    Wu H; Zhu K; Jatoi I; Shah M; Shriver CD; Potter J
    Breast Cancer Res Treat; 2007 Mar; 101(3):317-24. PubMed ID: 16821080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening controversy: too much or not enough?
    Pivot X; Viguier J; Touboul C; Morère JF; Blay JY; Coscas Y; Lhomel C; Eisinger F
    Eur J Cancer Prev; 2015 Jun; 24 Suppl():S73-6. PubMed ID: 26016791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attending the breast screening programme after breast cancer treatment: a population-based study.
    de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
    Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large population survey: strengths and limits. Methodology of the EDIFICE survey.
    Roussel C; Touboul C
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S5-7. PubMed ID: 21245682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organized colorectal cancer screening programmes: how to optimize efficiency in the general population.
    Calazel-Benque A; Viguier J; Roussel C; Pivot X; Eisinger F; Blay JY; Coscas Y; Morère JF
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S20-5. PubMed ID: 21245676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.